Champlain Investment Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutanix
NTNX
|
+$99.3M |
| 2 |
Brown-Forman Class B
BF.B
|
+$68.2M |
| 3 |
NEWR
New Relic, Inc.
NEWR
|
+$57.8M |
| 4 |
CMD
Cantel Medical Corporation
CMD
|
+$54.9M |
| 5 |
BlackLine
BL
|
+$53.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hormel Foods
HRL
|
+$90.6M |
| 2 |
Helen of Troy
HELE
|
+$67.3M |
| 3 |
RHT
Red Hat Inc
RHT
|
+$53.2M |
| 4 |
DATA
Tableau Software, Inc.
DATA
|
+$48.6M |
| 5 |
NUVA
NuVasive, Inc.
NUVA
|
+$37.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.32% |
| 2 | Technology | 19.66% |
| 3 | Industrials | 15.63% |
| 4 | Financials | 13.6% |
| 5 | Consumer Staples | 12.46% |
Similar funds
Champlain Investment Partners's Q4 2018 Portfolio in Review
As of Q4 2018, Champlain Investment Partners held 125 positions worth $9.84B, down 13% from $11.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Champlain Investment Partners deployed $331M of net new capital in Q4 2018, opening 7 new positions and adding to 65 existing holdings. Its largest new stake was Nutanix: 2,404,770 shares worth $100M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Hormel Foods, an estimated $90.6M trimmed.
- Champlain Investment Partners's largest Q4 2018 buy was Nutanix: 2,404,770 shares worth $100M.
- Champlain Investment Partners added most to New Relic, Inc. in Q4 2018, an estimated $57.8M increase.
- Champlain Investment Partners's biggest Q4 2018 reduction was Hormel Foods, cutting an estimated $90.6M.
- Champlain Investment Partners fully exited MINDBODY, Inc. Class A Common Stock in Q4 2018, selling an estimated $16M.
- Champlain Investment Partners's ten largest holdings make up 19% of its $9.84B portfolio in Q4 2018.
- Champlain Investment Partners opened 7 new positions and closed 6 in Q4 2018.
- Champlain Investment Partners's portfolio value fell 13% quarter-over-quarter to $9.84B.
Based on Champlain Investment Partners's 13F filing for Q4 2018, filed 13 Feb 2019.